Trial Profile
Double Blind Placebo Controlled Multicenter Trial for Prevention of IMT Progression in the Ischemic Stroke Patients With High Risk of Cerebral Hemorrhage With Cilostazol and Probucol
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cilostazol (Primary) ; Aspirin; Probucol
- Indications Stroke
- Focus Therapeutic Use
- Acronyms PICASSO-IMT
- 23 Dec 2015 Planned End Date changed from 1 Sep 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov.
- 23 Dec 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Sep 2016 as reported by ClinicalTrials.gov.
- 02 Jul 2015 New trial record